Cargando…
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
Rapid advances in immunotherapy have identified adoptive cell transfer as one of the most promising approaches for the treatment of cancers. Large numbers of cancer reactive T lymphocytes can be generated ex vivo from patient blood by genetic modification to express chimeric antigen receptors (CAR)...
Autores principales: | Tantalo, Daniela GM, Oliver, Amanda J, von Scheidt, Bianca, Harrison, Aaron J, Mueller, Scott N, Kershaw, Michael H, Slaney, Clare Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154965/ https://www.ncbi.nlm.nih.gov/pubmed/34035114 http://dx.doi.org/10.1136/jitc-2021-002555 |
Ejemplares similares
-
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
por: Oliver, Amanda J, et al.
Publicado: (2020) -
Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
por: Chan, Jack D., et al.
Publicado: (2020) -
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers
por: Harrison, Aaron J, et al.
Publicado: (2021) -
Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
por: Chan, Jack D, et al.
Publicado: (2020) -
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
por: VanSeggelen, Heather, et al.
Publicado: (2015)